MEKK1 Mediates Transcriptional Repression through Interaction with PKD1 Promoter-Bound p53 Protein

Strategic Insights -

Researchers at Northwest Missouri State University have discovered a novel mechanism by which MEKK1 regulates transcriptional activity through an interaction with p53, a tumor suppressor protein. MEKK1, a key MAP3 kinase, translocates to the nucleus and acts as a co-repressor with p53 to down-regulate PKD1 transcriptional activity. This repression is not dependent on MEKK1 kinase activity, suggesting alternative pathways are involved. The study also found that stress-pathway stimuli, including TNFa, can induce PKD1 repression through MEKK1 activation, which may contribute to cyst formation.

Key Takeaways:

  • MEKK1, a MAP3 kinase, regulates transcriptional activity through an interaction with p53 at the PKD1 promoter.
  • MEKK1 translocates to the nucleus and acts as a co-repressor with p53 to down-regulate PKD1 transcriptional activity.
  • The repression does not require MEKK1 kinase activity, excluding the need for an Mekk1 phosphorylation cascade.
  • Stress-pathway stimuli, including TNFa, can induce PKD1 repression through MEKK1 activation.
  • MEKK1-p53 interaction at the PKD1 promoter suggests a new mechanism by which abnormally elevated stress-pathway stimuli might directly down-regulate the PKD1 gene.
  • This mechanism may cause haploinsufficiency and cyst formation in autosomal dominant polycystic kidney disease (PKD1).
  • The study was published in the Journal of Biological Chemistry in 2010.
  • Researchers at Northwest Missouri State University conducted the study.

Statistics:

  • 50: The volume number of the Journal of Biological Chemistry where the study was published.
  • 38818-31: The page numbers of the study published in the Journal of Biological Chemistry.
  • 2010: The year the study was published in the Journal of Biological Chemistry.
  • 1: The gene most frequently mutated in autosomal dominant polycystic kidney disease (PKD1).
  • 1: The MEKK1-p53 interaction at the PKD1 promoter suggests a new mechanism by which abnormally elevated stress-pathway stimuli might directly down-regulate the PKD1 gene.

Sources:

  • M.R. Islam and colleagues, Northwest Missouri State University, Department of Chemistry. (2010). MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein. Journal of Biological Chemistry, 285(50), 38818-31.
  • Clinical Oncology Week editors. (2011). MEKK1 Mediates Transcriptional Repression through Interaction with PKD1 Promoter-Bound p53 Protein. Clinical Oncology Week via NewsRx.com.